MSF Field Research > 1 Published Research and Commentary > Leishmaniasis/Kala Azar > Sodium Stibogluconate (SSG) & Paromomycin Combination Compared to SSG for Visceral Leishmaniasis in East Africa: A Randomised Controlled Trial

Please use this identifier to cite or link to this item:     LinkedIn     Citeulike     Connotea     Facebook     Stumble it!

Download this article:
View/Open File Description Size Format
Musa et al. - 2012 - Sodium Stibogluconate (SSG) & Paromomycin Combination Compared to SSG for Visceral Leishmaniasis in East Africa A Ran.pdfMain Article290KbAdobe PDF

Title: Sodium Stibogluconate (SSG) & Paromomycin Combination Compared to SSG for Visceral Leishmaniasis in East Africa: A Randomised Controlled Trial
Authors: Musa, Ahmed
Khalil, Eltahir
Hailu, Asrat
Olobo, Joseph
Balasegaram, Manica
Omollo, Raymond
Edwards, Tansy
Rashid, Juma
Mbui, Jane
Musa, Brima
Abuzaid, Abuzaid Abdalla
Ahmed, Osama
Fadlalla, Ahmed
El-Hassan, Ahmed
Mueller, Marius
Mucee, Geoffrey
Njoroge, Simon
Manduku, Veronica
Mutuma, Geoffrey
Apadet, Lilian
Lodenyo, Hudson
Mutea, Dedan
Kirigi, George
Yifru, Sisay
Mengistu, Getahun
Hurissa, Zewdu
Hailu, Workagegnehu
Weldegebreal, Teklu
Tafes, Hailemariam
Mekonnen, Yalemtsehay
Makonnen, Eyasu
Ndegwa, Serah
Sagaki, Patrick
Kimutai, Robert
Kesusu, Josephine
Owiti, Rhoda
Ellis, Sally
Wasunna, Monique
Affiliation: Institute of Endemic Diseases, University of Khartoum, Khartoum, Sudan; Addis Ababa University, Addis Ababa, Ethiopia; Makerere University, Kampala, Uganda; Médecins Sans Frontières-Holland, Amsterdam, The Netherlands; Drugs for Neglected Diseases initiative (DNDi), Geneva, Switzerland; MRC Tropical Epidemiology Group, London School of Hygiene and Tropical Medicine, London, United Kingdom; Centre for Clinical Research, Kenya Medical Research Institute, Nairobi, Kenya; Faculty of Medicine, Gedaref University, Gedaref, Sudan; Gondar University, Gondar, Ethiopia; Arba Minch Hospital, Regional Health Bureau of SNNPR State, Arba Minch, Ethiopia; University of Nairobi, Nairobi, Kenya; Amudat Hospital, Amudat, Uganda
Citation: PLoS Negl Trop Dis. 2012 Jun;6(6):e1674
Publisher: Public Library of Science
Journal: PLoS Neglected Tropical Diseases
Issue Date: Jun-2012
DOI: 10.1371/journal.pntd.0001674
PubMed ID: 22724029
Additional Links:
Abstract: Alternative treatments for visceral leishmaniasis (VL) are required in East Africa. Paromomycin sulphate (PM) has been shown to be efficacious for VL treatment in India.
Type: Article
Language: en
Keywords: visceral leishmaniasia
ISSN: 1935-2735
Rights: Archived with thanks to PLoS Neglected Tropical Diseases and Open Access
Appears in topics: Leishmaniasis/Kala Azar

Related articles on PubMed
Geographical variation in the response of visceral leishmaniasis to paromomycin in East Africa: a multicentre, open-label, randomized trial.
Hailu A, Musa A, Wasunna M, Balasegaram M, Yifru S, Mengistu G, Hurissa Z, Hailu W, Weldegebreal T, Tesfaye S, Makonnen E, Khalil E, Ahmed O, Fadlalla A, El-Hassan A, Raheem M, Mueller M, Koummuki Y, Rashid J, Mbui J, Mucee G, Njoroge S, Manduku V, Musibi A, Mutuma G, Kirui F, Lodenyo H, Mutea D, Kirigi G, Edwards T, Smith P, Muthami L, Royce C, Ellis S, Alobo M, Omollo R, Kesusu J, Owiti R, Kinuthia J, Leishmaniasis East Africa Platform (LEAP) group
2010 Oct 26
Paromomycin for the treatment of visceral leishmaniasis in Sudan: a randomized, open-label, dose-finding study.
Musa AM, Younis B, Fadlalla A, Royce C, Balasegaram M, Wasunna M, Hailu A, Edwards T, Omollo R, Mudawi M, Kokwaro G, El-Hassan A, Khalil E
2010 Oct 26
Safety and efficacy of miltefosine alone and in combination with sodium stibogluconate and liposomal amphotericin B for the treatment of primary visceral leishmaniasis in East Africa: study protocol for a randomized controlled trial.
Omollo R, Alexander N, Edwards T, Khalil EA, Younis BM, Abuzaid AA, Wasunna M, Njoroge N, Kinoti D, Kirigi G, Dorlo TP, Ellis S, Balasegaram M, Musa AM
2011 Jun 30
Safety and efficacy of single dose versus multiple doses of AmBisome for treatment of visceral leishmaniasis in eastern Africa: a randomised trial.
Khalil EA, Weldegebreal T, Younis BM, Omollo R, Musa AM, Hailu W, Abuzaid AA, Dorlo TP, Hurissa Z, Yifru S, Haleke W, Smith PG, Ellis S, Balasegaram M, EL-Hassan AM, Schoone GJ, Wasunna M, Kimutai R, Edwards T, Hailu A
See all 115 articles

All Items in MSF are protected by copyright, with all rights reserved, unless otherwise indicated.


OR Logo Powered by Open Repository | Cookies


MSF logo MSF Field Research

May 27, 2015